advertisement
Lumigan/Cosopt Study Group 1
Showing records 1 to 1 | Display all abstracts from Lumigan/Cosopt Study Group9900 A three-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension
Coleman AL; Lerner F; Bernstein P; Whitcup SM; Lumigan/Cosopt Study Group
Ophthalmology 2003; 110: 2362-2368